ALLIED HEALTHCARE PRODUCTS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On November 23, 2022, Allied Healthcare Products, Inc. (the "Company") received written notice from the Listing Qualifications Department of The Nasdaq Stock Market notifying the Company that, as a result of its delay in filing its Form 10-Q for the quarter ended September 30, 2022, it is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). The Company has a period of 60 days from its receipt of the notice to submit a plan to regain compliance with the Nasdaq Listing Rules.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following exhibit index lists the exhibits that are either

    filed or furnished with this Current Report on Form 8-K.




  99.1     Press Release of the Company dated November 28, 2022

104      Cover Page Interactive Data File (Embedded within the Inline XBRL
         document and included in Exhibit)

© Edgar Online, source Glimpses